Market Place
Sourcing Support
Hillstream Enters into an Agreement to Acquire a Asset for Chronic Pruritis
11 Sep 2023 //
GLOBENEWSWIRE
Hillstream to Present at H.C. Wainwright 25th Annual Investment Conference
08 Sep 2023 //
GLOBENEWSWIRE
Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference
09 Aug 2023 //
GLOBENEWSWIRE
Hillstream Advances Next-Gen Multispecific Antibodies with HSB-3215
20 Jul 2023 //
GLOBENEWSWIRE
Hillstream Announces Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors
10 Jul 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 & HER3 ADC
06 Jul 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Strengthens its BOD with Appointment of Kelly Anderson
15 May 2023 //
GLOBENEWSWIRE
Hillstream BioPharma to Present at Upcoming May 2023 Investor
02 May 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Closing of Public Offering of Common Stock
02 May 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Proposed Public Offering
27 Apr 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Pricing of Public Offering
27 Apr 2023 //
GLOBENEWSWIRE
Hillstream Selects OncoBay Clinical to Advance HSB-1216
13 Apr 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216
10 Apr 2023 //
GLOBENEWSWIRE
Hillstream Bio to Participate in Two Major Industry Conferences in April 2023
28 Mar 2023 //
GLOBENEWSWIRE
Hillstream to Attend the 35th Annual ROTH Conference on March 12-14, 2023
28 Feb 2023 //
GLOBENEWSWIRE
Hillstream Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
15 Feb 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Signs Agreement with Applied Biomedical Science Institute
13 Feb 2023 //
GLOBENEWSWIRE
Hillstream Provides Webcast for its R&D Day on February 14th, 2023 at 10:00am ET
13 Feb 2023 //
GLOBENEWSWIRE
Hillstream Demonstrated Greater Tumor Inhibition Combining Pembrolizumab
10 Feb 2023 //
GLOBENEWSWIRE
Hillstream Announces Acceptance of Abstract at AACR Highlighting HSB-510
08 Feb 2023 //
GLOBENEWSWIRE
Hillstream to Host R&D Day to Showcase its Emerging Immuno-oncology Pipeline
06 Feb 2023 //
GLOBENEWSWIRE
Hillstream Signs an Exclusive Option Agreement to Advance Anti-MUC1-C Agents
31 Jan 2023 //
GLOBENEWSWIRE
Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference
17 Jan 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Develop of Proprietary Targeted Biologics, Knob
01 Dec 2022 //
GLOBENEWSWIRE
Hillstream BioPharma to Present at the RHK Capital Disruptive Growth Conference
22 Nov 2022 //
GLOBENEWSWIRE
Hillstream’s Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing
18 Oct 2022 //
GLOBENEWSWIRE
Hillstream BioPharma, Inc. to Present at Upcoming Investor Conferences
06 Oct 2022 //
GLOBENEWSWIRE
Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress
08 Jul 2022 //
GLOBENEWSWIRE
Hillstream Announces Collaboration with Sapien Biosciences in Cancer Treatments
27 Jun 2022 //
GLOBENEWSWIRE
Hillstream BioPharma Provides Corporate Update
02 Jun 2022 //
GLOBENEWSWIRE
Hillstream to Present at BioNJ`s 12th Annual BioPartnering Virtual Conference
05 May 2022 //
GLOBENEWSWIRE
Hillstream BioPharma R&D Day Highlights Ferroptosis, and much more
02 Mar 2022 //
GLOBENEWSWIRE
Hillstream BioPharma Receives ODD for HSB-1216 in Uveal Melanoma
16 Feb 2022 //
GLOBENEWSWIRE
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
14 Feb 2022 //
ACCESSWIRE
Hillstream Announces Acceptance of Abstract at AACR 2022 HSB-510
01 Feb 2022 //
PRESS RELEASE
Hillstream BioPharma and University of Massachusetts Chan Medical School
31 Jan 2022 //
ACCESSWIRE
Hillstream BioPharma Announces Closing of Initial Public Offering
14 Jan 2022 //
PRESS RELEASE
Hillstream BioPharma Announces Pricing of Initial Public Offering
11 Jan 2022 //
PRESS RELEASE
Hillstream BioPharma Adds Leading Cancer Drug Development Executive
11 Mar 2021 //
ACCESSWIRE
Hillstream BioPharma Presentations at 2020 AACR Virtual Annual Meeting II
19 May 2020 //
GLOBENEWSWIRE
